FeaturedGeneticsNeurosciencePsychology·October 5, 2019·5 min readWhat are personality disorders and how are they treated?With at least 6% of the general population and up to 60% of psychiatric patients having a personality disorder, a new report looks at the biological causes and treatment options for personality disorders.Read More
FeaturedNeurosciencePsychology·October 5, 2019·5 min readLong-term study data shows DBS is effective treatment for most severe form of depressionLong term outcome data of patients with treatment-resistant depression found subcallosal cingulate deep brain stimulation (SCC DBS) was both effective at relieving symptoms and safe.Read More
FeaturedGeneticsNeurosciencePsychology·October 5, 2019·3 min readIs there such a thing as an addictive personality?Researchers examine the psychology and genetics of why some people are more prone to addiction-like behaviors than others.Read More
FeaturedNeurologyNeuroscienceNeuroscience VideosOpen Neuroscience Articles·October 4, 2019·6 min readStudy pinpoints Alzheimer’s plaque emergence early and deep in the brainResearchers use SWITCH technology to label amyloid plaques in mouse models of Alzheimer's disease so they could be imaged in fine detail at different ages. They were consistently able to see the plaques first emerged in deep brain structures and tracked circuits, such as the Papez memory circuit, to spread throughout the brain as the animal aged.Read More
FeaturedGeneticsNeurologyNeuroscience·October 4, 2019·4 min readTargeting certain rogue T cells prevents and reverses multiple sclerosis: Mouse studyTH17 cells produced increased amounts of SerpinB1, a protein implicated in multiple sclerosis symptoms. SerpinB1 cells were identified with antibodies targeting the CXCR6 surface protein. Using monoclonal antibodies to target CXCR6, the cells disappeared significantly, and the mice primed to develop MS did not develop the disease.Read More
FeaturedNeurosciencePsychology·October 4, 2019·3 min readPromising steps towards hope for a treatment for schizophreniaMu-opioid receptor (MOR) levels are significantly reduced in the striatum in those with schizophrenia. A lack of MOR system stimulation contributes to negative feelings, such as a lack of motivation and anhedonia, associated with the condition. Increasing MOR levels could help to reduce some of the symptoms of schizophrenia.Read More
FeaturedGeneticsNeuroscience·October 3, 2019·3 min readGenetics researchers find new neurodevelopmental syndromeNKAP-related syndrome, a newly identified neurodevelopmental disorder caused by mutations in the NKPA gene, causes developmental delays, intellectual disabilities, behavioral abnormalities, and musculoskeletal problems in children.Read More
FeaturedNeurosciencePsychology·October 3, 2019·3 min readAnticipating performance can hinder memoryPerformance anticipation reduces memory for pre-performance information by diverting attention away from that information.Read More
FeaturedNeurologyNeuroscience·October 3, 2019·3 min readPesticides likely caused ‘Havana syndrome’ that affected Cuba-based diplomatsInitially believed to be an acoustic attack, researchers now believe they have pinpointed a possible cause of the bizarre neurological symptoms reported by diplomats in Cuba in 2016. Researchers say a possible source for 'Havana syndrome' is exposure to cholinesterase inhibitors via organophosphorus insecticides.Read More
FeaturedNeurosciencePsychology·October 3, 2019·3 min readPoor mental and physical health in pregnancy linked to infant sleep problemsPoor prepartum and postpartum physical and mental health was associated with persistent severe sleep problems in their babies.Read More
FeaturedNeuroscience·October 3, 2019·6 min readKey to learning and forgetting identified in sleeping brainUsing optogenetics to dampen delta waves of rats during sleep resulted in weaker memory reactivation and promoted forgetting. The findings could have significant implications for treating PTSD in humans.Read More
FeaturedNeurologyNeuroscience·October 3, 2019·5 min readParkinson’s disease is also present in the bloodParkinson's disease involves monocytic alterations in the blood. The cells have reduced viability and are unresponsive to specific stimuli, which could have relevant consequences for the progression of Parkinson's. Immune modulation medications may be a new treatment option to inhibit neurodegeneration associated with PD.Read More